Jan. 16, 2025 Repost from Omniscope and BIHUB -- Happy New Year! Omniscope joins forces with Barça Innovation Hub to develop immunology solutions for optimal athlete health and gets featured on New York Times.
Barça Innovation Hub (BIHUB) has reached an agreement to join the shareholding of Omniscope, a groundbreaking tech start-up that is building the world’s largest immune database. This partnership will merge cutting-edge immunology technology with elite sports science to develop new applications for monitoring health and optimizing athlete performance.
Omniscope’s patented technologies leverage AI applied to data generated from high-res immune cell characterization to drive new products designed to improve athlete resilience and recovery. Omniscope and BIHUB will be liaising in the creation of bespoke solutions for training and injury prevention and recovery processes, applying insights tailored to meet the stringent demands of high-performance athletes.
Omniscope’s mission includes democratizing access to health for everyone, everywhere, by unlocking the full potential of the immune system. Both Omniscope and BIHUB work from the conviction that advancements in this field can transform traditional healthcare by creating solutions that enhance health, performance, and resilience not only for elite athletes, but also for everyone else.
With this investment, Omniscope has become the ninth start-up in BIHUB’s portfolio, following on from Visualfy, OLIVER, Onalabs, CeleBreak, Made of Genes, Fyxbody, Rimbarlat, and Genomcore, thus further consolidating BIHUB’s position as a driver of innovation in the sports and technology sectors.
Statement by Holger Heyn, Co-founder of Omniscope:
“Omniscope teaming up with FC Barcelona brings Immune cell tracking to the Champions League. Our technology will closely monitor the player's immune system and contribute to the prevention of injuries and the speedy recovery of players."
Statement by Joan Laporta, President of FC Barcelona:
“Through the Barça Innovation Hub, we are positioning FC Barcelona at the forefront of innovation in sports health. This latest move, joining Omniscope’s shareholding, is a giant leap forward in this sense. Omniscope applies pioneering technologies that combine data management and artificial intelligence within the field of immunology, an essential area that is a necessary part of the present and, above all, the future of medicine.”
Omniscope unveiled its co-developed athletic performance platform at Mobile World Congress 2025. Be among the first to explore your very own immune system — sign up for early access at www.omniscope.ai/app today!
About Omniscope
Omniscope is building the world’s biggest immune database to offer access to healthcare for everyone, everywhere, by unlocking the potential of immune data. Through patented experimental lab and AI technologies, Omniscope generates unprecedented high-res immune insights, empowering scientists and healthcare providers to discover complex patterns and make accurate predictions of immune responses. Its mission is to drive advances in personalized medicine and set a new benchmark in immune health.